Skip to main content
Fig. 2 | BMC Cardiovascular Disorders

Fig. 2

From: Ticagrelor monotherapy after a short course of dual antiplatelet therapy with ticagrelor plus aspirin following percutaneous coronary intervention in patients with versus without diabetes mellitus: a meta-analysis of randomized trials

Fig. 2

Adverse cardiovascular outcomes with Ticagrelor monotherapy after a short course of dual antiplatelet therapy (DAPT) with Ticagrelor plus aspirin following percutaneous coronary intervention (PCI) in patients with versus without diabetes mellitus

Back to article page